Bruker Corp
Bruker Corp (BRKR) Covered Calls
As of September 25, 2026, BRKR has 30 covered call opportunities in the coming three months. Return ranges from 4.8 to 51.6% until expiration. Annualized return ranges from 19.4 to 217.1%. The nearest expiration is October 16, 2026. Maximum potential profit is $3,300.
Read more
Running BRKR covered calls helps you generate consistent income from Bruker Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Bruker Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best BRKR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if BRKR stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling BRKR covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Bruker Corp covered call is worth writing.
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits.
It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Income-focused investors, long-term BRKR holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling BRKR covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Bruker Corp covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile54.76% Neutral
- Market cap (M$)9,778
- 52 weeks high-1.72%
- 52 weeks low113.29%
- Analyst recommendationBuy
2.13 - Target price$60.00
-6.51% below the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-02
- P/E—
- Future P/E26.79
- EPS (ttm)-0.70
- EPS growth next 5 years15.06%
As of September 25, 2026
| 2026-11-20 | 57 | 85.00 | 32.81 | 0.70 | 2.60 | 2170.00 | 33.91 | 217.12 | -1.09 | +0.19 | 0 | 1.90 |
| 2026-12-18 | 85 | 90.00 | 40.63 | 0.35 | 2.50 | 2635.00 | 41.17 | 176.80 | -0.55 | +0.16 | 12 | 2.15 |
| 2026-10-16 | 22 | 70.00 | 9.38 | 0.65 | 2.90 | 665.00 | 10.39 | 172.39 | -1.02 | +0.31 | 161 | 2.25 |
| 2026-11-20 | 57 | 80.00 | 25.00 | 0.40 | 3.40 | 1640.00 | 25.63 | 164.09 | -0.63 | +0.23 | 6 | 3.00 |
| 2026-10-16 | 22 | 67.50 | 5.47 | 2.10 | 2.80 | 560.00 | 8.75 | 145.17 | -3.28 | +0.39 | 103 | 0.70 |
| 2026-12-18 | 85 | 85.00 | 32.81 | 0.50 | 3.30 | 2150.00 | 33.59 | 144.26 | -0.78 | +0.21 | 181 | 2.80 |
| 2026-11-20 | 57 | 75.00 | 17.19 | 2.50 | 4.10 | 1350.00 | 21.09 | 135.07 | -3.91 | +0.33 | 0 | 1.60 |
| 2026-12-18 | 85 | 80.00 | 25.00 | 1.35 | 4.00 | 1735.00 | 27.11 | 116.41 | -2.11 | +0.27 | 228 | 2.65 |
| 2026-11-20 | 57 | 70.00 | 9.38 | 4.20 | 5.50 | 1020.00 | 15.94 | 102.06 | -6.56 | +0.43 | 1 | 1.30 |
| 2026-12-18 | 85 | 75.00 | 17.19 | 2.85 | 5.10 | 1385.00 | 21.64 | 92.93 | -4.45 | +0.36 | 766 | 2.25 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best BRKR covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→